Rhinocerebral Mucormycosis with Cerebral Extension Successfully Treated with Adjunctive Hyperbaric Oxygen Therapy

Archives of Otolaryngology--Head and Neck Surgery

Volumn 114, Issue 7, 1988, Pages 791-794

  Couch, Leslie ^a   Theilen, Frank ^b   Mader, Jon T ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; KETOCONAZOLE;

ADULT; BRAIN ABSCESS; BRAIN INFECTION; CASE REPORT; FEMALE; HUMAN; HYPERBARIC OXYGEN; MUCORMYCOSIS; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PRIORITY JOURNAL; RHINITIS;

ADULT; AMPHOTERICIN B; BRAIN ABSCESS; BRAIN DISEASES; CASE REPORT; COMBINED MODALITY THERAPY; DEBRIDEMENT; FEMALE; HUMAN; HYPERBARIC OXYGENATION; KETOCONAZOLE; MIDDLE AGE; MUCORMYCOSIS; NOSE DISEASES; PROGNOSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0023941066     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archotol.1988.01860190095032     Document Type: Article

References (21)

1. Abramson E, Wilson D, Arky RA: Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Ann Intern Med 1967;66:735–742.
2. Maniglia A, Minz D, Novak S: Cephalic phycomycosis: A report of 80 cases. Laryngoscope 1982;92:755–760.
3. Abedi E, Sismanis A, Choi K, et al: Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984; 94:1060–1062.
4. Battock DJ, Grausz H, Bobrowsky M, et al: Alternate-day amphotericin B therapy in the treatment of rhinocerebral phycomycosis (mucormycosis). Ann Intern Med 1968;68:122–137.
5. Bergstrom L, Hemenway WG, Barnhart RA: Rhinocerebral and otologic mucormycosis. Ann Otol Rhinol Laryngol 1970;79:70–81.
6. Ginsberg J: Cerebral phycomycosis (mucormycosis) with ocular involvement. Am J Ophthalmol 1966;62:900–905.
7. Pillsbury HC, Fischer ND: Rhinocerebral mucormycosis. Arch Otolaryngol Head Neck Surg 1977;103:600–604.
8. Ferstenfed JE, Cohen SH, Rose HD, et al: Chronic rhinocerebral phycomycosis in association with diabetes. Postgrad Med J 1977;53:337–342.
9. Welser PA, Makley TA, Werling K: Cerebro-rhino-orbital phycomycosis: A case report. Ann Ophthalmol 1980;12:459–463.
10. Hamill R, Oney LA, Crane LR: Successful therapy for rhinocerebral mucormycosis with associated bilateral brain abscesses. Arch Intern Med 1983;143:581–583.
11. Gregory JE, Golden A, Haymaker W: Mucormycosis of the central nervous system: A report of three cases. Bull Johns Hopkins Hosp 1943;73:405–419.
12. Isaacson C, Stern SE: Gastrointestinal mucormycosis in infancy. S Afr Med J 1961; 35:581–584.
13. Price JC, Stevens DL: Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980;90:737–747.
14. Nathan MD, Keller AP, Lerner CJ, et al: Entomophthorales infection of the maxillofacial region. Laryngoscope 1982;92:767–769.
15. Mader JT, Brown GL, Guckian JC, et al: A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis 1980;142:915–922.
16. Mandell GL: Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. Infect Immun 1974;9:337–341.
17. Hohn DC, MacKay RD, Halliday B, et al: The effect of oxygen tension on the microbicidal function of leukocytes in wounds and in vitro. Surg Forum 1976;27:18–20.
18. Hunt TK, Pai MP: The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972;135:756–758.
19. Hunt TK, Zederfeldt B, Goldstick TK: Oxygen and healing. Am J Surg 1969;118:521–525.
20. Gudewicz TM, Mader JT, Davis CP: Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans. Aviat Space Environ Med 1987;58:673–678.
21. Cairney WJ: The effect of hyperbaric oxygen on certain growth features of four dermatophytes, Frank J. Seiley Research Laboratory Technical Report 80-005. Washington, DC, Air Force Systems Command, 1980.